Sign in

CIK 0001724521 · Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473898435
Phone
(510) 694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
  1. 4 Planned sale Chief Operating Officer sold 50,292 shares at an average $14.92 ($750,412)
  2. 4 Planned sale Chief Accounting Officer sold 2,831 shares at $13.00 ($36,803)
  3. 4 Planned sale Chief Accounting Officer sold 1,579 shares at $11.88 ($18,758)
  4. 4 Grant or award Director acquired 13,300 shares (grant or award)
  5. 4 Grant or award Director acquired 13,300 shares (grant or award)
  6. 4 Grant or award Director acquired 13,300 shares (grant or award)
  7. 4 Grant or award Director acquired 13,300 shares (grant or award)
  8. 4 Grant or award Director acquired 13,300 shares (grant or award)
  9. 4 Grant or award Director acquired 13,300 shares (grant or award)
  10. 4 Grant or award Director acquired 13,300 shares (grant or award)
  11. 4 Open-market buy Director bought 20,000 shares at $10.06 ($201,200)
  12. 4 Open-market buy Chief Executive Officer bought 19,800 shares at $10.18 ($201,465)
  13. 4 Open-market buy 10% owner bought 1,363,636 shares at $11.00 ($14,999,996)
  14. 4 Grant or award Chief Medical Officer acquired 75,193 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award General Counsel acquired 37,000 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 165,000 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Chief Operating Officer acquired 50,000 shares (grant or award)

Page 3 of 15 · 290 filings